← back to database
Life-sciences growth-capital specialist investing flexible permanent capital in commercial-stage tools, diagnostics, biopharma services and related healthcare-infrastructure companies from initial revenue through profitability.
Lead / follow
Specialization
Generalist / Specialist
Specialist
Latest fund size
>$200M permanent capital added to investment platform
Latest fund vintage
2025
Investing team
- Austin DukeManaging Director
Bill SniderPartner
Calvin AubreyVice President
Daniel FriedmanManaging Director
Henry DervishiAssociate
Lars HananPartner
Matt McFarlandPartner
Max WeisSenior Associate
Michael CaspaniManaging Director
Tim JohnsonPartner
How to reach them
Notable investments
Insphero, Axol Bioscience, EpiCypher, Harvard Bioscience, Cayman Chemical, Active Motif, Solvias, Quartzy